National COVID-19 Clinical Evidence Taskforce recommendations for remdesivir unchanged

Retrieved on: 2020-12-18 06:26:34

Tags for this article:

Organic compounds

Chemistry

Health sciences

COVID-19 drug development

Nucleotides

Remdesivir

Coronavirus disease

The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach

Extracorporeal membrane oxygenation

COVID-19 drug repurposing research

Management of COVID-19

Click the tags to see associated articles and topics

National COVID-19 Clinical Evidence Taskforce recommendations for remdesivir unchanged. View article details on hiswai:

Excerpt

Taskforce recommendations for <b>remdesivir</b> unchanged following detailed analysis of disease severity subgroups. The National COVID-19 Clinical ...

Article found on: paramedics.org

View Original Article